What is the share price of Arvee Laboratories (India) Ltd (ARVEE) today?
The share price of ARVEE as on 4th July 2025 is ₹192.56. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Arvee Laboratories (India) Ltd (ARVEE) share?
The past returns of Arvee Laboratories (India) Ltd (ARVEE) share are- Past 1 week: 19.87%
- Past 1 month: 3.02%
- Past 3 months: 35.38%
- Past 6 months: 14.88%
- Past 1 year: 3.16%
- Past 3 years: 134.12%
- Past 5 years: 342.16%
What are the peers or stocks similar to Arvee Laboratories (India) Ltd (ARVEE)?
The peers or stocks similar to Arvee Laboratories (India) Ltd (ARVEE) include:What is the market cap of Arvee Laboratories (India) Ltd (ARVEE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Arvee Laboratories (India) Ltd (ARVEE) is ₹212.20 Cr as of 4th July 2025.What is the 52 week high and low of Arvee Laboratories (India) Ltd (ARVEE) share?
The 52-week high of Arvee Laboratories (India) Ltd (ARVEE) is ₹235.79 and the 52-week low is ₹126.54.What is the PE and PB ratio of Arvee Laboratories (India) Ltd (ARVEE) stock?
The P/E (price-to-earnings) ratio of Arvee Laboratories (India) Ltd (ARVEE) is 99.16. The P/B (price-to-book) ratio is 7.29.Which sector does Arvee Laboratories (India) Ltd (ARVEE) belong to?
Arvee Laboratories (India) Ltd (ARVEE) belongs to the Materials sector & Specialty Chemicals sub-sector.How to buy Arvee Laboratories (India) Ltd (ARVEE) shares?
You can directly buy Arvee Laboratories (India) Ltd (ARVEE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Arvee Laboratories (India) Ltd
ARVEE Share Price
192.562.85% (-5.64)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ARVEE Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
ARVEE Performance & Key Metrics
ARVEE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 99.16 | 7.29 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 28.03 | 3.51 | 1.55% |
ARVEE Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
ARVEE Company Profile
Arvee Laboratories provides specialty chemical products. The Company is primarily engaged in manufacturing of Polymer Modifiers, Contrast Media Intermediates and Drug Intermediates
FLUOROCHEM
PE Ratio
70.85
70.85
1Y Return
8.54%
8.54%
Buy Reco %
55.56
55.56
NAVINFLUOR
PE Ratio
84.77
84.77
1Y Return
34.82%
34.82%
Buy Reco %
61.54
61.54
VINATIORGA
PE Ratio
49.75
49.75
1Y Return
0.11%
0.11%
Buy Reco %
83.33
83.33
AARTIIND
PE Ratio
52.20
52.20
1Y Return
33.67%
33.67%
Buy Reco %
70.59
70.59
FINEORG
PE Ratio
39.36
39.36
1Y Return
0.87%
0.87%
Buy Reco %
70.00
70.00
ARVEE Forecast
ARVEE Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
ARVEE
ARVEE
Income
Balance Sheet
Cash Flow
Annual Normal View
ARVEE Income Statement
ARVEE Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 34.93 | 48.01 | 55.25 | 45.77 | 47.96 | 40.79 | 62.70 | 30.99 | 39.14 | 39.15 | ||||||||||
Raw Materials | 19.86 | 28.76 | 38.19 | 30.24 | 29.07 | 23.19 | 38.49 | 16.87 | 34.88 | 34.88 | ||||||||||
| Power & Fuel Cost | 1.06 | 1.27 | 1.54 | 1.50 | 1.72 | 1.60 | 2.38 | 1.82 | ||||||||||||
| Employee Cost | 2.54 | 2.78 | 2.49 | 2.79 | 5.54 | 5.69 | 6.14 | 5.93 | ||||||||||||
| Selling & Administrative Expenses | 0.68 | 3.24 | 2.89 | 3.95 | 2.74 | 2.97 | 3.42 | 2.50 | ||||||||||||
| Operating & Other expenses | 4.38 | 4.56 | 3.62 | 0.92 | 2.26 | 1.20 | 3.64 | 0.29 | ||||||||||||
EBITDA | 6.41 | 7.40 | 6.52 | 6.37 | 6.63 | 6.14 | 8.63 | 3.58 | 4.26 | 4.27 | ||||||||||
| Depreciation/Amortization | 2.07 | 2.15 | 2.35 | 2.29 | 2.41 | 2.32 | 2.08 | 1.50 | 1.15 | 1.16 | ||||||||||
| PBIT | 4.34 | 5.25 | 4.17 | 4.08 | 4.22 | 3.82 | 6.55 | 2.08 | 3.11 | 3.11 | ||||||||||
| Interest & Other Items | 3.48 | 3.33 | 1.63 | 0.99 | 0.58 | 0.37 | 0.39 | 0.25 | 0.25 | 0.25 | ||||||||||
| PBT | 0.86 | 1.92 | 2.54 | 3.09 | 3.64 | 3.45 | 6.16 | 1.83 | 2.86 | 2.86 | ||||||||||
| Taxes & Other Items | -0.70 | 0.83 | 0.28 | 0.80 | 0.96 | 0.88 | 2.05 | 0.78 | 0.72 | 0.72 | ||||||||||
| Net Income | 1.56 | 1.09 | 2.26 | 2.29 | 2.68 | 2.57 | 4.11 | 1.05 | 2.14 | 2.14 | ||||||||||
| EPS | 0.96 | 0.57 | 1.03 | 1.04 | 1.62 | 2.33 | 3.73 | 0.95 | 1.95 | 1.94 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARVEE Company Updates
ARVEE Stock Peers
ARVEE Past Performance & Peer Comparison
ARVEE Past Performance & Peer Comparison
Comparing 3 stocks from
MaterialsSpecialty Chemicals
Compare valuation-basic on Screener
MaterialsSpecialty Chemicals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Arvee Laboratories (India) Ltd | 99.16 | 7.29 | — |
| Gujarat Fluorochemicals Ltd | 70.85 | 6.52 | 0.09% |
| Navin Fluorine International Ltd | 84.77 | 10.27 | 0.24% |
| Vinati Organics Ltd | 49.75 | 8.19 | 0.39% |
ARVEE Stock Price Comparison
Compare ARVEE with any stock or ETFCompare ARVEE with any stock or ETF
ARVEE
ARVEE Holdings
ARVEE Shareholdings
ARVEE Promoter Holdings Trend
ARVEE Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
ARVEE Institutional Holdings Trend
ARVEE Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ARVEE Shareholding Pattern
ARVEE Shareholding Pattern
ARVEE Shareholding History
ARVEE Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing ARVEE stock
smallcases containing ARVEE stock
Looks like this stock is not in any smallcase yet.
ARVEE Events
ARVEE Events
ARVEE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ARVEE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ARVEE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ARVEE has not given any dividends in last 5 years
ARVEE Dividends
ARVEE Dividends
Hmm, looks like data is unavailable here. Please come back after some timeARVEE Stock News & Opinions
ARVEE Stock News & Opinions
Articles & Videos
Earnings
Arvee Laboratories (India) standalone net profit declines 41.67% in the March 2025 quarter
Net profit of Arvee Laboratories (India) declined 41.67% to Rs 0.07 crore in the quarter ended March 2025 as against Rs 0.12 crore during the previous quarter ended March 2024. Sales rose 5.05% to Rs 6.45 crore in the quarter ended March 2025 as against Rs 6.14 crore during the previous quarter ended March 2024. For the full year,net profit rose 104.76% to Rs 2.15 crore in the year ended March 2025 as against Rs 1.05 crore during the previous year ended March 2024. Sales rose 26.82% to Rs 38.49 crore in the year ended March 2025 as against Rs 30.35 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales6.456.14 5 38.4930.35 27 OPM %3.4113.03 -9.389.88 - PBDT0.360.96 -63 4.023.33 21 PBT0.090.59 -85 2.871.83 57 NP0.070.12 -42 2.151.05 105 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Arvee Laboratories (India) to hold board meeting
Arvee Laboratories (India) will hold a meeting of the Board of Directors of the Company on 9 May 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Arvee Laboratories (India) standalone net profit declines 37.50% in the December 2024 quarter
Net profit of Arvee Laboratories (India) declined 37.50% to Rs 0.15 crore in the quarter ended December 2024 as against Rs 0.24 crore during the previous quarter ended December 2023. Sales rose 15.71% to Rs 8.91 crore in the quarter ended December 2024 as against Rs 7.70 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales8.917.70 16 OPM %3.826.88 - PBDT0.480.67 -28 PBT0.200.32 -38 NP0.150.24 -38 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Arvee Laboratories (India)to declare Quarterly Results
Arvee Laboratories (India) will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Arvee Laboratories (India) standalone net profit rises 366.67% in the September 2024 quarter
Net profit of Arvee Laboratories (India) rose 366.67% to Rs 0.98 crore in the quarter ended September 2024 as against Rs 0.21 crore during the previous quarter ended September 2023. Sales rose 40.63% to Rs 12.53 crore in the quarter ended September 2024 as against Rs 8.91 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales12.538.91 41 OPM %11.977.74 - PBDT1.610.70 130 PBT1.310.28 368 NP0.980.21 367 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Arvee Laboratories (India) to convene board meeting
Arvee Laboratories (India) will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Arvee Laboratories (India) to hold AGM
Arvee Laboratories (India) announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Earnings
Arvee Laboratories (India) standalone net profit rises 91.84% in the June 2024 quarter
Net profit of Arvee Laboratories (India) rose 91.84% to Rs 0.94 crore in the quarter ended June 2024 as against Rs 0.49 crore during the previous quarter ended June 2023. Sales rose 39.47% to Rs 10.60 crore in the quarter ended June 2024 as against Rs 7.60 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales10.607.60 39 OPM %14.5312.89 - PBDT1.571.00 57 PBT1.260.65 94 NP0.940.49 92 Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Arvee Laboratories (India) to convene board meeting
Arvee Laboratories (India) will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Arvee Laboratories (India) standalone net profit rises 6.00% in the June 2021 quarter
3 years agoBusiness Standard
Over the last 5 years, revenue has grown at a yearly rate of -3.08%, vs industry avg of 11.47%
Over the last 5 years, market share decreased from 0.09% to 0.04%
Over the last 5 years, net income has grown at a yearly rate of -1.35%, vs industry avg of 7.76%